InvestSMART

Antisense Therapeutics Limited (ASX: ANP) - Announcements

Current share price for ANP : $0.058 0.003 (4.92%)+

ASX company news and announcements for Antisense Therapeutics Limited (ANP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Antisense Therapeutics Limited (ANP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Antisense Therapeutics Limited (ANP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Antisense Therapeutics Limited (ANP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$52 Results of Annual General Meeting 18 Dec 2020 12:24PM $0.120 $0.058 fallen by 51.67%
$52 Annual General Meeting Chairman's Address 18 Dec 2020 10:03AM $0.140 $0.058 fallen by 58.57%
$52 2020 Annual General Meeting Presentation 18 Dec 2020 9:09AM $0.150 $0.058 fallen by 61.33%
$52 EC grants Orphan Drug Designation for ATL1102 in DMD 14 Dec 2020 8:58AM $0.094 $0.058 fallen by 38.30%
$52 Receipt of R&D Tax Incentive payment 8 Dec 2020 8:54AM $0.100 $0.058 fallen by 42%
$52 Ceasing to be a substantial holder 3 Dec 2020 11:37AM $0.100 $0.058 fallen by 42%
$52 Change of Director's Interest Notice (x 2) 3 Dec 2020 9:05AM $0.105 $0.058 fallen by 44.76%
$52 Appendix 2A and 708A notice 2 Dec 2020 6:09PM $0.105 $0.058 fallen by 44.76%
$52 ANP to present at Several Upcoming Virtual Conferences 2 Dec 2020 9:37AM $0.105 $0.058 fallen by 44.76%
$52 Antisense Therapeutics closes SPP oversubscribed 30 Nov 2020 9:55AM $0.099 $0.058 fallen by 41.41%
$52 Antisense Therapeutics to present at Australian Equities Day 27 Nov 2020 9:04AM $0.098 $0.058 fallen by 40.82%
$52 Reminder - Antisense Therapeutics SPP Closing Date 25 Nov 2020 9:36AM $0.100 $0.058 fallen by 42%
$52 Antisense Therapeutics Dual lists on the FSE 23 Nov 2020 9:07AM $0.100 $0.058 fallen by 42%
$52 ANP Share Purchase Plan Booklet 19 Nov 2020 4:22PM $0.100 $0.058 fallen by 42%
$52 Becoming a substantial holder 18 Nov 2020 3:49PM $0.105 $0.058 fallen by 44.76%
$52 Notice of Annual General Meeting/Proxy Form 17 Nov 2020 6:47PM $0.100 $0.058 fallen by 42%
$52 Appendix 2A and Cleansing Notice 17 Nov 2020 6:16PM $0.100 $0.058 fallen by 42%
$52 Investor Presentation 11 Nov 2020 9:57AM $0.115 $0.058 fallen by 49.57%
$52 ANP raises A$7.3 million from Oversubscribed Placement 11 Nov 2020 9:56AM $0.115 $0.058 fallen by 49.57%
$52 Proposed issue of Securities - ANP 11 Nov 2020 9:55AM $0.115 $0.058 fallen by 49.57%
$52 ATL1102 Orphan Drug Designation from EMA 11 Nov 2020 9:55AM $0.115 $0.058 fallen by 49.57%
$52 Trading Halt 10 Nov 2020 9:24AM $0.115 $0.058 fallen by 49.57%
$52 ANP to apply for dual listing on Frankfurt Stock Exchange 9 Nov 2020 9:07AM $0.100 $0.058 fallen by 42%
$52 Appendix 4G and Corporate Governance Statement 29 Oct 2020 4:54PM $0.115 $0.058 fallen by 49.57%
$52 Annual Report 29 Oct 2020 4:52PM $0.115 $0.058 fallen by 49.57%

176 - 200 of 707 results

Page 8 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.